Comment
doi: 10.1016/S0140-6736(00)04425-1.
Drug therapy for management of obesity
- PMID: 11421206
- DOI: 10.1016/S0140-6736(00)04425-1
Item in Clipboard
Comment
Drug therapy for management of obesity
Lancet.
.
No abstract available
Comment on
-
Effect of sibutramine on weight maintenance after weight loss: a randomised trial. STORM Study Group. Sibutramine Trial of Obesity Reduction and Maintenance.Lancet. 2000 Dec 23-30;356(9248):2119-25. doi: 10.1016/s0140-6736(00)03491-7. Lancet. 2000. PMID: 11191537 Clinical Trial.
Similar articles
-
Sibutramine in cardiovascular disease: is SCOUT the new STORM on the horizon?Eur Heart J. 2007 Dec;28(23):2830-1. doi: 10.1093/eurheartj/ehm493. Epub 2007 Nov 5. Eur Heart J. 2007. PMID: 17984134 No abstract available.
-
Weight loss and health-related quality of life.Am J Manag Care. 2001 Sep;7(9):926-7. Am J Manag Care. 2001. PMID: 11570025 No abstract available.
-
[Pharmacotherapy for weight loss in patients with type 2 diabetes].Ugeskr Laeger. 2007 Aug 13;169(33):2619-22. Ugeskr Laeger. 2007. PMID: 17725907 Danish. No abstract available.
-
Long-term pharmacotherapy for obesity.Obes Res. 2004 Dec;12 Suppl:163S-6S. doi: 10.1038/oby.2004.283. Obes Res. 2004. PMID: 15687412 Review.
-
Does drug therapy of obesity have a future?Can J Clin Pharmacol. 2000 Autumn;7(3):133-4. Can J Clin Pharmacol. 2000. PMID: 11044757 Review. No abstract available.
Cited by
-
Pharmacotherapy for obesity.Drugs. 2005;65(10):1391-418. doi: 10.2165/00003495-200565100-00006. Drugs. 2005. PMID: 15977970 Review.
-
Safety of drug therapies used for weight loss and treatment of obesity.Drug Saf. 2006;29(4):277-302. doi: 10.2165/00002018-200629040-00001. Drug Saf. 2006. PMID: 16569079 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
